8C60.0

ICD-11 MMS 2026-01

Drug-induced myasthenia gravis

Description

Some drugs can have clear effects on Myasthenia Gravis, including Neuromuscular junction blockers, antibiotics, prednisone, chloroquine, D-penicillamine, interferons, and others. In rapid-onset drug-induced Myasthenia Gravis, myasthenic signs develop within days which rapidly disappear after drug withdrawal. Anti-Acetylcholinesterase antibodies are absent. This disorder may unmask a pre-existing neuromuscular transmission disorder or may exacerbate pre-existing Myasthenia Gravis, i.e. subclinical Myasthenia Gravis becomes manifest after drug treatment, or known MG becomes more severe. Certain drugs are linked with aggravation of Myasthenia Gravis, including pain management medications, tricyclic antidepressants and some antiepileptic medications, and should be used with caution.

Index terms

  • Drug-induced myasthenia gravis
  • medicament-induced myasthenia gravis

Exclusions from above levels

  • 05 – Endocrine, nutritional or metabolic diseases
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 19 – Certain conditions originating in the perinatal period
Show allHide
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • 8C60.Y – Other specified myasthenia gravis
  • 8C60.Z – Myasthenia gravis, unspecified

Foundation entity

Drug-induced myasthenia gravis – http://id.who.int/icd/entity/600370025

Allowed postcoordination axes

Part of: 8C60: Myasthenia gravis › 08: Diseases of the nervous system